Cargando…
Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials
Experimental therapeutic oncology agents are often combined to circumvent tumor resistance to individual agents. However, most combination trials fail to demonstrate sufficient safety and efficacy to advance to a later phase. This study collected survey data on phase 1 combination therapy trials ide...
Autores principales: | Paller, Channing J., Huang, Erich P., Luechtefeld, Thomas, Massett, Holly A., Williams, Christopher C., Zhao, Jinxiu, Gravell, Amy E., Tamashiro, Tami, Reeves, Steven A., Rosner, Gary L., Carducci, Michael A., Rubinstein, Lawrence, Ivy, S. Percy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558040/ https://www.ncbi.nlm.nih.gov/pubmed/31214592 http://dx.doi.org/10.3389/fmed.2019.00122 |
Ejemplares similares
-
Applications for open access normalized synthesis in metastatic prostate cancer trials
por: Luechtefeld, Thomas, et al.
Publicado: (2022) -
A Review of Pomegranate in Prostate Cancer
por: Paller, Channing J., et al.
Publicado: (2017) -
Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments
por: Luechtefeld, Thomas, et al.
Publicado: (2020) -
Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller, Channing J, et al.
Publicado: (2012) -
Author Correction: Functionally Enigmatic Genes in Cancer: Using TCGA Data to Map the Limitations of Annotations
por: Maertens, Alexandra, et al.
Publicado: (2020)